TUBB and prostate neoplasm: High level of tubulin beta-3 chain has been linked to resistance to antitubulin agents such as taxanes and vinorelbine and lower overall survival in nonsmall cell lung cancer (NSCLC) [35–37] and prostate tumor patients [38].